Xeris Biopharma Holdings, Inc. (XERS)
Nasdaq: XERS · CIK 0001867096 · United States
Every official Xeris Biopharma Holdings, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open XERS filings
Xeris Biopharma Holdings, Inc. documents
- Xeris Biopharma Holdings, Inc. 10-K 2026XERS 10-K 2026: annual report for fiscal 2026
- Xeris Biopharma Holdings, Inc. 10-K 2025XERS 10-K 2025: annual report for fiscal 2025
- Xeris Biopharma Holdings, Inc. 10-K 2024XERS 10-K 2024: annual report for fiscal 2024
- Xeris Biopharma Holdings, Inc. 10-K 2023XERS 10-K 2023: annual report for fiscal 2023
- Xeris Biopharma Holdings, Inc. 10-K 2022XERS 10-K 2022: annual report for fiscal 2022
- Xeris Biopharma Holdings, Inc. 10-Q 2026XERS 10-Q 2026: quarterly report for fiscal 2026
- Xeris Biopharma Holdings, Inc. 10-Q 2025XERS 10-Q 2025: quarterly report for fiscal 2025
- Xeris Biopharma Holdings, Inc. 10-Q 2024XERS 10-Q 2024: quarterly report for fiscal 2024
- Xeris Biopharma Holdings, Inc. 10-Q 2023XERS 10-Q 2023: quarterly report for fiscal 2023
- Xeris Biopharma Holdings, Inc. 10-Q 2022XERS 10-Q 2022: quarterly report for fiscal 2022
- Xeris Biopharma Holdings, Inc. 8-K 2026XERS 8-K 2026: current report for fiscal 2026
- Xeris Biopharma Holdings, Inc. 8-K 2025XERS 8-K 2025: current report for fiscal 2025
- Xeris Biopharma Holdings, Inc. 8-K 2024XERS 8-K 2024: current report for fiscal 2024
- Xeris Biopharma Holdings, Inc. 8-K 2023XERS 8-K 2023: current report for fiscal 2023
- Xeris Biopharma Holdings, Inc. 8-K 2022XERS 8-K 2022: current report for fiscal 2022
- Xeris Biopharma Holdings, Inc. DEF 14A 2026XERS DEF 14A 2026: proxy statement for fiscal 2026
- Xeris Biopharma Holdings, Inc. DEF 14A 2025XERS DEF 14A 2025: proxy statement for fiscal 2025
- Xeris Biopharma Holdings, Inc. DEF 14A 2024XERS DEF 14A 2024: proxy statement for fiscal 2024
- Xeris Biopharma Holdings, Inc. DEF 14A 2023XERS DEF 14A 2023: proxy statement for fiscal 2023
- Xeris Biopharma Holdings, Inc. DEF 14A 2022XERS DEF 14A 2022: proxy statement for fiscal 2022
- Xeris Biopharma Holdings, Inc. Form 4 2026XERS Form 4 2026: insider trading filing for fiscal 2026
- Xeris Biopharma Holdings, Inc. Form 4 2025XERS Form 4 2025: insider trading filing for fiscal 2025
- Xeris Biopharma Holdings, Inc. Form 4 2024XERS Form 4 2024: insider trading filing for fiscal 2024
- Xeris Biopharma Holdings, Inc. Form 4 2023XERS Form 4 2023: insider trading filing for fiscal 2023
- Xeris Biopharma Holdings, Inc. Form 4 2022XERS Form 4 2022: insider trading filing for fiscal 2022
- Xeris Biopharma Holdings, Inc. S-1 2026XERS S-1 2026: registration statement for fiscal 2026
- Xeris Biopharma Holdings, Inc. S-1 2025XERS S-1 2025: registration statement for fiscal 2025
- Xeris Biopharma Holdings, Inc. S-1 2024XERS S-1 2024: registration statement for fiscal 2024
- Xeris Biopharma Holdings, Inc. S-1 2023XERS S-1 2023: registration statement for fiscal 2023
- Xeris Biopharma Holdings, Inc. S-1 2022XERS S-1 2022: registration statement for fiscal 2022
- Xeris Biopharma Holdings, Inc. 13F 2026XERS 13F 2026: institutional holdings for fiscal 2026
- Xeris Biopharma Holdings, Inc. 13F 2025XERS 13F 2025: institutional holdings for fiscal 2025
- Xeris Biopharma Holdings, Inc. 13F 2024XERS 13F 2024: institutional holdings for fiscal 2024
- Xeris Biopharma Holdings, Inc. 13F 2023XERS 13F 2023: institutional holdings for fiscal 2023
- Xeris Biopharma Holdings, Inc. 13F 2022XERS 13F 2022: institutional holdings for fiscal 2022
More companies